September 17, 2019—New York, US Stem cells, capable of unrestricted self-renewal, are taken as resourceful cell origins in the field of clinical and pharmacological applications. Creative Biolabs, intending to solve the challenges faced today that only limited studies have been carried out over the stem cell’s innovative development methods, is dedicated to making breakthroughs supported with its advanced platforms and professional scientists. To cater to the differentiated customers’ requests, Creative Biolabs offers all-around basic research solutions, consisting Induced Pluripotent Stem Cells (iPSC) Service, Mesenchymal Stem Cells (MSCs) Service, Organoid and 3D Bioprinting Service, Stem Cell Editing Services for Stem Cell, and Assay Development Service, etc.
1. The package of iPSC composes iPSC reprogramming, culture, pluripotent characterization, genome editing, and differentiation services, which can also be independently provided in accordance with a specific order. Characterized as highly customizable, efficient, and cost-effective, the solutions ensure satisfactory results.
2. Mesenchymal stem cells (MSC), are taken as a powerful therapeutic tool in the area of ST therapy because of their latent capability of self-growth and omnidirectional differentiation. MSC isolation & expansion, MSC characterization, and MSC differentiation solutions stay readily available for customers working on the MSC stream of ST projects, which guarantee long-lasting viability, multi-facet potentials of the resulting cells and the nature of originally provided cells unchanged after the system process of MSC manufacturing from Creative Biolabs.
3. Evolved from the techniques (inkjet, laster-assisted, extrusion and stereolithographic bioprinting) developed in the past decade, the 3D bioprinting (other names: additive manufacturing) services take advantage of the abreast-of-the-art techniques, covering the prophase, metaphase and anaphase of bioprinting. The application range is broad, ranging from medical, cosmetic, food, and even to education. Supported by the 3D bioprinting from Creative Biolabs, various tissues can be generated to assist with drug research, which will run a low risk of cell rejection and relieve from the burden of animal testing.
4. Operation of gene editing calls for sophisticated technologies, which make it impossible for all research institutes or drug manufacturers to conduct. With the aim of solving this headache perplexing the customers, Creative Biolabs is giving a hand with its advanced platforms.
CRISPR (Clustered Regularly Interspaced Short Palindromic Repeats) service
TALEN (Transcription Activator-like Effector Nucleases) service
ZFN (Zinc Fingers) service
Recombinant technology service
Features: high-end technology; experts’ support; efficiency; systematic pipeline.
Aside from the basic research services, featured stem cell therapy development services and stem cell manufacturing services pertain to be readily accessible if required. The ultimate objective of Creative Biolabs is to bring the already used ST cells to a higher level, professionally and efficiently. If more information about the stem cell therapy or the company required, please visit https://www.creative-biolabs.com/stem-cell-therapy/.
About the Company
Creative Biolabs has years of experience in providing high-quality products and services in the field of biopharmaceuticals for customers on a worldwide scale. Supported with a group of scientists and advanced technology platforms, the one-stop solutions will be more focused, not only on developing high standard product, but also technical support to meet the need for stem cell therapy development.
Company Name: Creative Biolabs
Contact Person: Candy Swift
Email: Send Email
Address:45-1 Ramsey Road
State: New York
Country: United States